Skip to main content

Table 1 Patients’ characteristics

From: The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer

 

Screening set (n = 63)

Validation set (n = 86)

Characteristics

n (%)

n (%)

Histology

  

Serous

28 (44.4)

86 (100.0)

Non-serous

35 (55.6) 1

-

FIGO

  

I

19 (30.2)

6 (7.0)

II

6 (9.5)

4 (4.7)

III

32 (50.8)

61 (70.9)

IV

6 (9.5)

15 (17.4)

Grade

  

Grade 1

10 (15.9)

6 (7.0)

Grade 2

20 (31.7)

19 (22.1)

Grade 3

33 (52.4)

61 (70.9)

Residual tumor

  

no

35 (55.6)

37 (43.0)

> 0 cm

28 (44.4)

49 (57.0)

ERα

  

positive

13 (20.6)

27 (31.4)

negative

49 (77.8)

55 (63.9)

missing

1 (1.5)

4 (4.7)

ERbeta

  

positive

45 (71.4)

14 (16.3)

negative

15 (23.8)

68 (79.0)

missing

3 (4.7)

4 (4.7)

PELP1

  

positive

48 (76.2)

21 (24.4)

negative

12 (19.0)

61 (70.9)

missing

3 (4.7)

4 (4.7)

  1. 1 Endometrioid: n= 16; Mucinous: n= 9; Undifferentiated carcinoma: n= 7; Clear cell carcinoma: n= 3;
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us